Next report date
Report period
Q4 2023
EPS estimate
—
Revenue estimate
—
116JPY
568.62 MJPY
20.13 BJPY
972.14 K
About SAPPORO CLINICAL LABORATORIES
Sector
Industry
Headquarters
Sapporo
Website
Employees (FY)
938
Founded
1965
ISIN
JP3321100004
FIGI
BBG000FHY1C2
Sapporo Clinical Laboratory Inc. engages in the business of clinical testing services for medical industries. It operates through the following segments: Clinical Testing, Dispensing Pharmacy, Medical Equipment Sales and Maintenance, and Others. The Clinical Testing segment provides contract laboratory tests for medical institutions. The Dispensing Pharmacy segment operates pharmacies that issue and dispense prescription medicines. The Medical Equipment Sales and Maintenance sells and maintains general and advanced medical and laboratory equipment. The Others segment develops, sells, and maintains clinical testing system software. The company was founded on September 22, 1965 and is headquartered in Sapporo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 9776 is 2124 JPY — it has increased by 67.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SAPSE exchange SAPPORO CLINICAL LABORATORIES stocks are traded under the ticker 9776.
SAPPORO CLINICAL LABORATORIES is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
9776 stock is 40.30% volatile and has beta coefficient of 0.15. Check out the list of the most volatile stocks — is SAPPORO CLINICAL LABORATORIES there?
Yes, you can track SAPPORO CLINICAL LABORATORIES financials in yearly and quarterly reports right on TradingView.
9776 stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in SAPPORO CLINICAL LABORATORIES price.
9776 net income for the last quarter is 85.68 M JPY, while the quarter before that showed 220.58 M JPY of net income which accounts for −61.16% change. Track more SAPPORO CLINICAL LABORATORIES financial stats to get the full picture.
Today SAPPORO CLINICAL LABORATORIES has the market capitalization of 3.60 B, it has increased by 6.36% over the last week.
SAPPORO CLINICAL LABORATORIES dividend yield was 1.82% in 2022, and payout ratio reached 13.49%. The year before the numbers were 1.77% and 7.51% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 9776 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAPPORO CLINICAL LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 938.00 employees. See our rating of the largest employees — is SAPPORO CLINICAL LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAPPORO CLINICAL LABORATORIES EBITDA is 1.13 B JPY, and current EBITDA margin is 7.62%. See more stats in SAPPORO CLINICAL LABORATORIES financial statements.